Laura Shawver is the founder of Silverback Therapeutics. Silverback Therapeutics has raised $210M in total funding. Latest round: Series C.
Laura Shawver is a biotech executive and board member. She served as Chief Executive Officer of Silverback Therapeutics until its acquisition by ARS Pharmaceuticals and has led other companies acquired by major pharmaceutical firms. Shawver holds a Ph.D. in Pharmacology and a B.S. in Microbiology from the University of Iowa.
Full founder directory · Investor directory · Company funding database · Fundraising library